+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Preclinical Imaging Market Size, Share & Trends Analysis Report by Type, Application, End Use, Region, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • January 2026
  • Region: Global
  • Grand View Research
  • ID: 3765909
The global preclinical imaging market size was valued at USD 1.05 billion in 2025 and is expected to reach USD 1.63 billion by 2033, growing at a CAGR of 5.6% from 2026 to 2033. This growth is driven by the rising prevalence of chronic diseases, increasing investments in drug development, and growing demand for non-invasive imaging techniques.

The adoption of advanced imaging modalities for early-stage research, coupled with the expansion of translational research initiatives, further accelerates market expansion.

Government initiatives, including grants and funding from organizations such as the National Institutes of Health (NIH) and similar agencies in Europe and Asia, are significantly enhancing preclinical research and bolstering the preclinical imaging market. For example, in September 2022, the NIH and the U.S. Department of Health and Human Services (DHHS) called for applications for milestone-driven preclinical vaccine development targeting Enterotoxigenic Escherichia coli (ETEC), Salmonella Paratyphi A, and Shigella species.

The program supported vaccine optimization, scale-up, safety, and efficacy testing, offering up to USD 750,000 annually over five years to help candidates reach clinical readiness. Eligible applicants included academic institutions, nonprofits, governments, and businesses. The National Institute of Allergy and Infectious Diseases (NIAID) planned to award USD 5.2 million across 4-6 projects to advance candidates toward FDA IND submission. This influx of funding allows researchers to invest in advanced platforms, develop new probes, and expand longitudinal studies, increasing demand in the preclinical in-vivo imaging market and supporting growth in segments like optical preclinical imaging.

Global Preclinical Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global preclinical imaging market based on type, application, end use and region:

Type Outlook (Revenue, USD Million, 2021-2033)

  • Modality
  • Reagent
  • Service

Application Outlook (Revenue, USD Million, 2021-2033)

  • Drug Discovery & Development
  • Toxicology & Pharmacokinetics Studies
  • Basic & Translational Research
  • Disease Mechanism & Pathophysiology Studies
  • Biomarker & Imaging Agent Validation
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Pharma and Biotech Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type Outlook
2.2.2. Application Outlook
2.2.3. End Use Outlook
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. Preclinical Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Preclinical Imaging Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Social landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Preclinical Imaging Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Preclinical Imaging Type Market Movement Analysis
4.3. Global Preclinical Imaging Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
4.4. Modality
4.4.1. Modality market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2. Optical Imaging (BLI & F)
4.4.2.1. Optical Imaging (BLI & F) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.3. Magnetic Resonance Imaging (MRI)
4.4.3.1. Magnetic Resonance Imaging (MRI) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.4. Positron Emission Tomography (PET)
4.4.4.1. Positron Emission Tomography (PET) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.5. Single Photon Emission Computed Tomography (SPECT)
4.4.5.1. Single Photon Emission Computed Tomography (SPECT) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.6. Computed Tomography (CT)
4.4.6.1. Computed Tomography (CT) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.7. Ultrasound Imaging (US)
4.4.7.1. Ultrasound Imaging (US) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.8. Photoacoustic Imaging (PAI)
4.4.8.1. Photoacoustic Imaging (PAI) market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9. Hybrid Imaging Systems
4.4.9.1. Hybrid Imaging Systems market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2. Bi-Modal
4.4.9.2.1. Bi-Modal market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2.2. SPECT-CT
4.4.9.2.2.1. SPECT-CT market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2.3. PET-CT
4.4.9.2.3.1. PET-CT market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2.4. SPECT-PET
4.4.9.2.4.1. SPECT-PET market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2.5. PET-MRI
4.4.9.2.5.1. PET-MRI market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2.6. Optical-CT
4.4.9.2.6.1. Optical-CT market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.2.7. Others
4.4.9.2.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.3. Tri-Modal
4.4.9.3.1. Tri-Modal market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.3.2. PET-SPECT-CT
4.4.9.3.2.1. PET-SPECT-CT market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.3.3. PET-SPECT-MRI
4.4.9.3.3.1. PET-SPECT-MRI market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.3.4. PET-CT-Optical
4.4.9.3.4.1. PET-CT-Optical market estimates and forecasts 2021 to 2033 (USD Million)
4.4.9.3.5. Others
4.4.9.3.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
4.4.10. Others
4.4.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Reagent
4.5.1. Reagent market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Service
4.6.1. Service market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Preclinical Imaging Application Market Movement Analysis
5.3. Global Preclinical Imaging Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Drug Discovery & Development
5.4.1. Drug Discovery & Development market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Toxicology & Pharmacokinetics Studies
5.5.1. Toxicology & Pharmacokinetics Studies market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Basic & Translational Research
5.6.1. Basic & Translational Research market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Disease Mechanism & Pathophysiology Studies
5.7.1. Disease Mechanism & Pathophysiology Studies market estimates and forecasts 2021 to 2033 (USD Million)
5.7.2. Oncology
5.7.2.1. Oncology market estimates and forecasts 2021 to 2033 (USD Million)
5.7.3. Cardiology
5.7.3.1. Cardiology market estimates and forecasts 2021 to 2033 (USD Million)
5.7.4. Neurology
5.7.4.1. Neurology market estimates and forecasts 2021 to 2033 (USD Million)
5.7.5. Infectious Diseases
5.7.5.1. Infectious Diseases market estimates and forecasts 2021 to 2033 (USD Million)
5.7.6. Immunology & Inflammation
5.7.6.1. Immunology & Inflammation market estimates and forecasts 2021 to 2033 (USD Million)
5.7.7. Others
5.7.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
5.8. Biomarker & Imaging Agent Validation
5.8.1. Biomarker & Imaging Agent Validation market estimates and forecasts 2021 to 2033 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Preclinical Imaging Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Preclinical Imaging End Use Market Movement Analysis
6.3. Global Preclinical Imaging Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Pharma and Biotech Companies
6.4.1. Pharma and biotech companies market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Contract Research Organizations (CROs)
6.5.1. Contract Research Organizations (CROs) market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Academic and Research Institutes
6.6.1. Academic and Research Institutes market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis By Type, Application, End Use
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework
7.5.1.4. Reimbursement structure
7.5.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement structure
7.5.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement structure
7.5.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. Regulatory framework
7.6.1.4. Reimbursement structure
7.6.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement structure
7.6.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement structure
7.6.3.5. France market estimates and forecasts 2021 to 2033 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Reimbursement structure
7.6.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Reimbursement structure
7.6.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Reimbursement structure
7.6.6.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Regulatory framework
7.6.7.4. Reimbursement structure
7.6.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Competitive scenario
7.6.8.3. Regulatory framework
7.6.8.4. Reimbursement structure
7.6.8.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement structure
7.7.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement structure
7.7.2.5. China market estimates and forecasts 2021 to 2033 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement structure
7.7.3.5. India market estimates and forecasts 2021 to 2033 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement structure
7.7.4.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement structure
7.7.5.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement structure
7.7.6.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement structure
7.8.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement structure
7.8.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement structure
7.9.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement structure
7.9.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement structure
7.9.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Regulatory framework
7.9.4.4. Reimbursement structure
7.9.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2025
8.4. Company Position Analysis
8.5. Company Categorization (Emerging Players, Innovators and Leaders)
8.6. Company Profiles
8.6.1. Cubresa Inc.
8.6.1.1. Company overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. Bruker Corporation
8.6.2.1. Company overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. Revvity (PerkinElmer, Inc)
8.6.3.1. Company overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. FUJIFILM VisualSonics
8.6.4.1. Company overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. Mediso Ltd.
8.6.5.1. Company overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. Rigaku (MILabs B.V.)
8.6.6.1. Company overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. MR Solutions
8.6.7.1. Company overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. Aspect Imaging
8.6.8.1. Company overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. TriFoil Imaging
8.6.9.1. Company overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives
8.6.10. Siemens Healthineers
8.6.10.1. Company overview
8.6.10.2. Financial performance
8.6.10.3. Product benchmarking
8.6.10.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America preclinical imaging market, By country, 2021-2033 (USD Million)
Table 3 North America preclinical imaging market, By type, 2021-2033 (USD Million)
Table 4 North America preclinical imaging market, By application, 2021-2033 (USD Million)
Table 5 North America preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 6 U.S. preclinical imaging market, By type, 2021-2033 (USD Million)
Table 7 U.S. preclinical imaging market, By application, 2021-2033 (USD Million)
Table 8 U.S. preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 9 Canada preclinical imaging market, By type, 2021-2033 (USD Million)
Table 10 Canada preclinical imaging market, By application, 2021-2033 (USD Million)
Table 11 Canada preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 12 Mexico preclinical imaging market, By type, 2021-2033 (USD Million)
Table 13 Mexico preclinical imaging market, By application, 2021-2033 (USD Million)
Table 14 Mexico preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 15 Europe preclinical imaging market, By country, 2021-2033 (USD Million)
Table 16 Europe preclinical imaging market, By type, 2021-2033 (USD Million)
Table 17 Europe preclinical imaging market, By application, 2021-2033 (USD Million)
Table 18 Europe preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 19 UK preclinical imaging market, By type, 2021-2033 (USD Million)
Table 20 UK preclinical imaging market, By application, 2021-2033 (USD Million)
Table 21 UK preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 22 Germany preclinical imaging market, By type, 2021-2033 (USD Million)
Table 23 Germany preclinical imaging market, By application, 2021-2033 (USD Million)
Table 24 Germany preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 25 France preclinical imaging market, By type, 2021-2033 (USD Million)
Table 26 France preclinical imaging market, By application, 2021-2033 (USD Million)
Table 27 France preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 28 Italy preclinical imaging market, By type, 2021-2033 (USD Million)
Table 29 Italy preclinical imaging market, By application, 2021-2033 (USD Million)
Table 30 Italy preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 31 Denmark preclinical imaging market, By type, 2021-2033 (USD Million)
Table 32 Denmark preclinical imaging market, By application, 2021-2033 (USD Million)
Table 33 Denmark preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 34 Sweden preclinical imaging market, By type, 2021-2033 (USD Million)
Table 35 Sweden preclinical imaging market, By application, 2021-2033 (USD Million)
Table 36 Sweden preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 37 Norway preclinical imaging market, By type, 2021-2033 (USD Million)
Table 38 Norway preclinical imaging market, By application, 2021-2033 (USD Million)
Table 39 Norway preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 40 Asia Pacific preclinical imaging market, By country, 2021-2033 (USD Million)
Table 41 Asia Pacific preclinical imaging market, By type, 2021-2033 (USD Million)
Table 42 Asia Pacific preclinical imaging market, By application, 2021-2033 (USD Million)
Table 43 Asia Pacific preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 44 Japan preclinical imaging market, By type, 2021-2033 (USD Million)
Table 45 Japan preclinical imaging market, By application, 2021-2033 (USD Million)
Table 46 Japan preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 47 China preclinical imaging market, By type, 2021-2033 (USD Million)
Table 48 China preclinical imaging market, By application, 2021-2033 (USD Million)
Table 49 China preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 50 India preclinical imaging market, By type, 2021-2033 (USD Million)
Table 51 India preclinical imaging market, By application, 2021-2033 (USD Million)
Table 52 India preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 53 Australia preclinical imaging market, By type, 2021-2033 (USD Million)
Table 54 Australia preclinical imaging market, By application, 2021-2033 (USD Million)
Table 55 Australia preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 56 South Korea preclinical imaging market, By type, 2021-2033 (USD Million)
Table 57 South Korea preclinical imaging market, By application, 2021-2033 (USD Million)
Table 58 South Korea preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 59 Thailand preclinical imaging market, By type, 2021-2033 (USD Million)
Table 60 Thailand preclinical imaging market, By application, 2021-2033 (USD Million)
Table 61 Thailand preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 62 Latin America preclinical imaging market, By Country, 2021-2033 (USD Million)
Table 63 Latin America preclinical imaging market, By type, 2021-2033 (USD Million)
Table 64 Latin America preclinical imaging market, By application, 2021-2033 (USD Million)
Table 65 Latin America preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 66 Brazil preclinical imaging market, By type, 2021-2033 (USD Million)
Table 67 Brazil preclinical imaging market, By application, 2021-2033 (USD Million)
Table 68 Brazil preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 69 Argentina preclinical imaging market, By type, 2021-2033 (USD Million)
Table 70 Argentina preclinical imaging market, By application, 2021-2033 (USD Million)
Table 71 Argentina preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 72 Middle East & Africa preclinical imaging market, By country, 2021-2033 (USD Million)
Table 73 Middle East & Africa preclinical imaging market, By type, 2021-2033 (USD Million)
Table 74 Middle East & Africa preclinical imaging market, By application, 2021-2033 (USD Million)
Table 75 Middle East & Africa preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 76 South Africa preclinical imaging market, By type, 2021-2033 (USD Million)
Table 77 South Africa preclinical imaging market, By application, 2021-2033 (USD Million)
Table 78 South Africa preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 79 Saudi Arabia preclinical imaging market, By type, 2021-2033 (USD Million)
Table 80 Saudi Arabia preclinical imaging market, By application, 2021-2033 (USD Million)
Table 81 Saudi Arabia preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 82 UAE preclinical imaging market, By type, 2021-2033 (USD Million)
Table 83 UAE preclinical imaging market, By application, 2021-2033 (USD Million)
Table 84 UAE preclinical imaging market, By end use, 2021-2033 (USD Million)
Table 85 Kuwait preclinical imaging market, By type, 2021-2033 (USD Million)
Table 86 Kuwait preclinical imaging market, By application, 2021-2033 (USD Million)
Table 87 Kuwait preclinical imaging market, By end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Preclinical imaging market: Market outlook
Figure 14 Preclinical imaging market competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Penetration and growth prospect mapping
Figure 18 Industry value chain analysis
Figure 19 Preclinical imaging market driver impact
Figure 20 Preclinical imaging restraint impact
Figure 21 Preclinical imaging market: type movement analysis
Figure 22 Preclinical imaging market: type outlook and key takeaways
Figure 23 Modality market estimates and forecast, 2021-2033
Figure 24 Optical Imaging (BLI & F) market estimates and forecast, 2021-2033
Figure 25 MRI market estimates and forecast, 2021-2033
Figure 26 PET market estimates and forecast, 2021-2033
Figure 27 SPECT market estimates and forecast, 2021-2033
Figure 28 CT market estimates and forecast, 2021-2033
Figure 29 Ultrasound Imaging (US) market estimates and forecast, 2021-2033
Figure 30 Photoacoustic Imaging (PAI) market estimates and forecast, 2021-2033
Figure 31 Hybrid Imaging Systems market estimates and forecast, 2021-2033
Figure 32 Bi-Modal market estimates and forecast, 2021-2033
Figure 33 SPECT-CT market estimates and forecast, 2021-2033
Figure 34 PET-CT market estimates and forecast, 2021-2033
Figure 35 SPECT-PET market estimates and forecast, 2021-2033
Figure 36 PET-MRI market estimates and forecast, 2021-2033
Figure 37 Optical-CT market estimates and forecast, 2021-2033
Figure 38 Others market estimates and forecast, 2021-2033
Figure 39 Tri-Modal market estimates and forecast, 2021-2033
Figure 40 PET-SPECT-CT market estimates and forecast, 2021-2033
Figure 41 PET-SPECT-MRI market estimates and forecast, 2021-2033
Figure 42 PET-CT-Optical market estimates and forecast, 2021-2033
Figure 43 Others market estimates and forecast, 2021-2033
Figure 44 Reagents market estimates and forecast, 2021-2033
Figure 45 Services market estimates and forecast, 2021-2033
Figure 46 Preclinical imaging market: application movement analysis
Figure 47 Preclinical imaging market: application outlook and key takeaways
Figure 48 Drug Discovery & Development market estimates and forecast, 2021-2033
Figure 49 Toxicology & Pharmacokinetics Studies market estimates and forecast, 2021-2033
Figure 50 Basic & Translational Research market estimates and forecast, 2021-2033
Figure 51 Disease Mechanism & Pathophysiology Studies market estimates and forecast, 2021-2033
Figure 52 Oncology market estimates and forecast, 2021-2033
Figure 53 Cardiology market estimates and forecast, 2021-2033
Figure 54 Neurology market estimates and forecast, 2021-2033
Figure 55 Infectious Diseases market estimates and forecast, 2021-2033
Figure 56 Immunology & Inflammation market estimates and forecast, 2021-2033
Figure 57 Others market estimates and forecast, 2021-2033
Figure 58 Biomarker & Imaging Agent Validation market estimates and forecast, 2021-2033
Figure 59 Others market estimates and forecast, 2021-2033
Figure 60 Preclinical imaging market: end use movement analysis
Figure 61 Preclinical imaging market: end use outlook and key takeaways
Figure 62 Pharma and biotech companies market estimates and forecast, 2021-2033
Figure 63 Contract Research Organizations (CROs) market estimates and forecast, 2021-2033
Figure 64 Academic and Research Institutes market estimates and forecast, 2021-2033
Figure 65 Others market estimates and forecast, 2021-2033
Figure 66 Global Preclinical Imaging Market: regional movement analysis
Figure 67 Global Preclinical Imaging Market: regional outlook and key takeaways
Figure 68 North America
Figure 69 North America market estimates and forecast, 2021-2033
Figure 70 U.S.
Figure 71 U.S. market estimates and forecast, 2021-2033
Figure 72 Canada
Figure 73 Canada market estimates and forecast, 2021-2033
Figure 74 Mexico
Figure 75 Mexico market estimates and forecast, 2021-2033
Figure 76 Europe
Figure 77 Europe. market estimates and forecast, 2021-2033
Figure 78 UK
Figure 79 UK market estimates and forecast, 2021-2033
Figure 80 Germany
Figure 81 Germany market estimates and forecast, 2021-2033
Figure 82 France
Figure 83 France market estimates and forecast, 2021-2033
Figure 84 Italy
Figure 85 Italy market estimates and forecast, 2021-2033
Figure 86 Spain
Figure 87 Spain market estimates and forecast, 2021-2033
Figure 88 Denmark
Figure 89 Denmark market estimates and forecast, 2021-2033
Figure 90 Sweden
Figure 91 Sweden market estimates and forecast, 2021-2033
Figure 92 Norway
Figure 93 Norway market estimates and forecast, 2021-2033
Figure 94 Asia Pacific
Figure 95 Asia Pacific market estimates and forecast, 2021-2033
Figure 96 Japan
Figure 97 Japan market estimates and forecast, 2021-2033
Figure 98 China
Figure 99 China market estimates and forecast, 2021-2033
Figure 100 India
Figure 101 India market estimates and forecast, 2021-2033
Figure 102 South Korea
Figure 103 South Korea market estimates and forecast, 2021-2033
Figure 104 Thailand
Figure 105 Thailand market estimates and forecast, 2021-2033
Figure 106 Australia
Figure 107 Australia market estimates and forecast, 2021-2033
Figure 108 Latin America
Figure 109 Latin America market estimates and forecast, 2021-2033
Figure 110 Brazil
Figure 111 Brazil market estimates and forecast, 2021-2033
Figure 112 Argentina
Figure 113 Argentina market estimates and forecast, 2021-2033
Figure 114 Middle East and Africa
Figure 115 Middle East and Africa. market estimates and forecast, 2021-2033
Figure 116 Saudi Arabia
Figure 117 Saudi Arabia market estimates and forecast, 2021-2033
Figure 118 South Africa
Figure 119 South Africa market estimates and forecast, 2021-2033
Figure 120 UAE
Figure 121 UAE market estimates and forecast, 2021-2033
Figure 122 Kuwait
Figure 123 Kuwait market estimates and forecast, 2021-2033
Figure 124 Participant categorization- Preclinical imaging market
Figure 125 Market share of key market players- Preclinical imaging market

Companies Mentioned

The leading players profiled in this Preclinical Imaging market report include:
  • Cubresa Inc.
  • Bruker Corporation
  • Revvity (PerkinElmer, Inc)
  • FUJIFILM VisualSonics
  • Mediso Ltd.
  • Rigaku (MILabs B.V.)
  • MR Solutions
  • Aspect Imaging
  • TriFoil Imaging
  • Siemens Healthineers

Table Information